139 related articles for article (PubMed ID: 7783318)
21. [Bacteriological evaluations of combination therapies with minocycline and beta-lactams for methicillin-resistant Staphylococcus aureus. I. Cefotiam plus minocycline].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R
Jpn J Antibiot; 1992 Jun; 45(6):597-604. PubMed ID: 1507393
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo effects of combinations of cefotaxime or other beta-lactams with rolitetracycline on methicillin-resistant Staphylococcus aureus.
Kobayashi S; Arai S; Hayashi S
Jpn J Antibiot; 1989 May; 42(5):1208-15. PubMed ID: 2746860
[TBL] [Abstract][Full Text] [Related]
23. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 1. Activities against Staphylococcus aureus].
Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1996 Feb; 49(2):194-202. PubMed ID: 8721079
[TBL] [Abstract][Full Text] [Related]
24. Combined effects of panipenem and aminoglycosides on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in vitro.
Katou K; Nakamura A; Kato T; Tonegawa K; Kutsuna T; Niwa T; Morita H; Itoh M
Chemotherapy; 2005 Oct; 51(6):387-91. PubMed ID: 16227698
[TBL] [Abstract][Full Text] [Related]
25. In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
Dosler S; Gerceker AA
Chemotherapy; 2011; 57(6):511-6. PubMed ID: 22302084
[TBL] [Abstract][Full Text] [Related]
26. In vitro synergistic activity between meropenem and other beta-lactams against methicillin-resistant Staphylococcus aureus.
Sumita Y; Mitsuhashi S
Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):77-84. PubMed ID: 1864279
[TBL] [Abstract][Full Text] [Related]
27. Ceftizoxime (FK 749) in vitro antibacterial activity.
Husson MO; Courcol R; Izard D; Leclerc H
Infection; 1984; 12(1):40-5. PubMed ID: 6323320
[TBL] [Abstract][Full Text] [Related]
28. [Combination effect of teicoplanin and beta-lactams on MRSA].
Otsuka Y; Yoshibe T; Namioka M; Ezaki T
Jpn J Antibiot; 2000 Dec; 53(12):643-51. PubMed ID: 11234220
[TBL] [Abstract][Full Text] [Related]
29. [In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems].
Kouda M
Jpn J Antibiot; 1993 Feb; 46(2):142-53. PubMed ID: 8331774
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of the new cephalosporins.
Brogard JM; Comte F
Antibiot Chemother (1971); 1982; 31():145-210. PubMed ID: 6277241
[No Abstract] [Full Text] [Related]
31. Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant
Tang HJ; Lai CC; Chen CC; Zhang CC; Weng TC; Yu WL; Chen HJ; Chiu YH; Ko WC; Chuang YC
Front Microbiol; 2017; 8():884. PubMed ID: 28572795
[TBL] [Abstract][Full Text] [Related]
32. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of cefotaxime against clinically significant pathogens.
Nakashio S; Nakamura M
Drugs; 1988; 35 Suppl 2():14-21. PubMed ID: 3260852
[TBL] [Abstract][Full Text] [Related]
34. Characterization of resistance phenotype and cephalosporin activity in oxacillin-resistant Staphylococcus aureus.
Mateos-Mora M; Knapp CC; Washington JA
Antimicrob Agents Chemother; 1988 Feb; 32(2):170-4. PubMed ID: 3364941
[TBL] [Abstract][Full Text] [Related]
35. [Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
Deguchi K; Yokota N; Koguchi M; Fukayama S; Nishimura Y; Nakane Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1987 Oct; 40(10):1752-61. PubMed ID: 3444015
[TBL] [Abstract][Full Text] [Related]
36. [Study on the drug sensitivity of multiple drug-resistant Staphylococcus aureus].
Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Satoh K; Toyonaga Y
Jpn J Antibiot; 1985 Aug; 38(8):2163-70. PubMed ID: 3852898
[TBL] [Abstract][Full Text] [Related]
37. Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus.
Yokota T; Yoshida R; Utsui Y; Tajima M
Drugs Exp Clin Res; 1985; 11(1):29-38. PubMed ID: 3915273
[TBL] [Abstract][Full Text] [Related]
38. [Studies on the combined effect of fosfomycin with sulbactam/cefoperazone on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa].
Niida M; Yoshida T; Kohmoto A; Ogawa M; Hashimoto H; Deguchi K
Jpn J Antibiot; 1994 Jan; 47(1):1-10. PubMed ID: 8114267
[TBL] [Abstract][Full Text] [Related]
39. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
[TBL] [Abstract][Full Text] [Related]
40. Concentration-dependent synergy and antagonism between cefoperazone and imipenem against methicillin-resistant Staphylococcus aureus.
Rand KH; Brown P
Antimicrob Agents Chemother; 1995 May; 39(5):1173-7. PubMed ID: 7625809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
